Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[An 18-year-old man had cystic fibrosis (CF) and insulin-resistant carbohydrate intolerance characterized by (1) obesity, basal hyperinsulinemia, and hyperglucagonemia; (2) impaired oral glucose tolerance; (3) hyperinsulinemia in response to oral and intravenous (IV) administration of glucose and to IV administration of tolbutamide; (4) exaggerated gastric inhibitory polypeptide secretion following orally administered glucose; and (5) diminished sensitivity to insulin administered IV compared with other patients with CF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP694136.RAj3cYg_-okU_oHUS7Z8NPy9ayl7ebTw7Ifd7M19Ap3_E130_assertion description "[An 18-year-old man had cystic fibrosis (CF) and insulin-resistant carbohydrate intolerance characterized by (1) obesity, basal hyperinsulinemia, and hyperglucagonemia; (2) impaired oral glucose tolerance; (3) hyperinsulinemia in response to oral and intravenous (IV) administration of glucose and to IV administration of tolbutamide; (4) exaggerated gastric inhibitory polypeptide secretion following orally administered glucose; and (5) diminished sensitivity to insulin administered IV compared with other patients with CF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP694136.RAj3cYg_-okU_oHUS7Z8NPy9ayl7ebTw7Ifd7M19Ap3_E130_provenance.
• NP512915.RASbeOCwd65QV93Us0qdUAyNcTWx1vSSvC022ruqt3e08130_assertion description "[An 18-year-old man had cystic fibrosis (CF) and insulin-resistant carbohydrate intolerance characterized by (1) obesity, basal hyperinsulinemia, and hyperglucagonemia; (2) impaired oral glucose tolerance; (3) hyperinsulinemia in response to oral and intravenous (IV) administration of glucose and to IV administration of tolbutamide; (4) exaggerated gastric inhibitory polypeptide secretion following orally administered glucose; and (5) diminished sensitivity to insulin administered IV compared with other patients with CF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP512915.RASbeOCwd65QV93Us0qdUAyNcTWx1vSSvC022ruqt3e08130_provenance.
• NP1008569.RAXaJt2HfyhJmNGv-mm_2snom05fd765JKBS3ptYFdR3E130_assertion description "[An 18-year-old man had cystic fibrosis (CF) and insulin-resistant carbohydrate intolerance characterized by (1) obesity, basal hyperinsulinemia, and hyperglucagonemia; (2) impaired oral glucose tolerance; (3) hyperinsulinemia in response to oral and intravenous (IV) administration of glucose and to IV administration of tolbutamide; (4) exaggerated gastric inhibitory polypeptide secretion following orally administered glucose; and (5) diminished sensitivity to insulin administered IV compared with other patients with CF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1008569.RAXaJt2HfyhJmNGv-mm_2snom05fd765JKBS3ptYFdR3E130_provenance.
• NP1305863.RADJ7bDvzgHWljPRmJbKxROM4ZGW9K3haK9VxSoLxoi2s130_assertion description "[An 18-year-old man had cystic fibrosis (CF) and insulin-resistant carbohydrate intolerance characterized by (1) obesity, basal hyperinsulinemia, and hyperglucagonemia; (2) impaired oral glucose tolerance; (3) hyperinsulinemia in response to oral and intravenous (IV) administration of glucose and to IV administration of tolbutamide; (4) exaggerated gastric inhibitory polypeptide secretion following orally administered glucose; and (5) diminished sensitivity to insulin administered IV compared with other patients with CF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1305863.RADJ7bDvzgHWljPRmJbKxROM4ZGW9K3haK9VxSoLxoi2s130_provenance.
• NP1305864.RAWLMZFhna7bXdvwQ33aMfCewC53HrD-xp1IfADXjplLQ130_assertion description "[An 18-year-old man had cystic fibrosis (CF) and insulin-resistant carbohydrate intolerance characterized by (1) obesity, basal hyperinsulinemia, and hyperglucagonemia; (2) impaired oral glucose tolerance; (3) hyperinsulinemia in response to oral and intravenous (IV) administration of glucose and to IV administration of tolbutamide; (4) exaggerated gastric inhibitory polypeptide secretion following orally administered glucose; and (5) diminished sensitivity to insulin administered IV compared with other patients with CF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1305864.RAWLMZFhna7bXdvwQ33aMfCewC53HrD-xp1IfADXjplLQ130_provenance.
• NP512103.RAsAO4kNVYIiMBmR6RajAeyv-phMAzRloKanIoiP_k91M130_assertion description "[An 18-year-old man had cystic fibrosis (CF) and insulin-resistant carbohydrate intolerance characterized by (1) obesity, basal hyperinsulinemia, and hyperglucagonemia; (2) impaired oral glucose tolerance; (3) hyperinsulinemia in response to oral and intravenous (IV) administration of glucose and to IV administration of tolbutamide; (4) exaggerated gastric inhibitory polypeptide secretion following orally administered glucose; and (5) diminished sensitivity to insulin administered IV compared with other patients with CF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP512103.RAsAO4kNVYIiMBmR6RajAeyv-phMAzRloKanIoiP_k91M130_provenance.
• NP1305861.RApTCOqYre-bUTVCtswUeAlGmM2piCM6OOszTyda4byaQ130_assertion description "[An 18-year-old man had cystic fibrosis (CF) and insulin-resistant carbohydrate intolerance characterized by (1) obesity, basal hyperinsulinemia, and hyperglucagonemia; (2) impaired oral glucose tolerance; (3) hyperinsulinemia in response to oral and intravenous (IV) administration of glucose and to IV administration of tolbutamide; (4) exaggerated gastric inhibitory polypeptide secretion following orally administered glucose; and (5) diminished sensitivity to insulin administered IV compared with other patients with CF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1305861.RApTCOqYre-bUTVCtswUeAlGmM2piCM6OOszTyda4byaQ130_provenance.
• NP425296.RA054igb-i6oW1-GMfu2m1sxrUgt6GqSRaSjds0sgpa7Y130_assertion description "[An 18-year-old man had cystic fibrosis (CF) and insulin-resistant carbohydrate intolerance characterized by (1) obesity, basal hyperinsulinemia, and hyperglucagonemia; (2) impaired oral glucose tolerance; (3) hyperinsulinemia in response to oral and intravenous (IV) administration of glucose and to IV administration of tolbutamide; (4) exaggerated gastric inhibitory polypeptide secretion following orally administered glucose; and (5) diminished sensitivity to insulin administered IV compared with other patients with CF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP425296.RA054igb-i6oW1-GMfu2m1sxrUgt6GqSRaSjds0sgpa7Y130_provenance.
• NP1007782.RAJLBozVeyqOfbNa9H_id1fVlxOHq_Qo8xOZ5savzoONk130_assertion description "[An 18-year-old man had cystic fibrosis (CF) and insulin-resistant carbohydrate intolerance characterized by (1) obesity, basal hyperinsulinemia, and hyperglucagonemia; (2) impaired oral glucose tolerance; (3) hyperinsulinemia in response to oral and intravenous (IV) administration of glucose and to IV administration of tolbutamide; (4) exaggerated gastric inhibitory polypeptide secretion following orally administered glucose; and (5) diminished sensitivity to insulin administered IV compared with other patients with CF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1007782.RAJLBozVeyqOfbNa9H_id1fVlxOHq_Qo8xOZ5savzoONk130_provenance.
• NP1305860.RA8yQiCiv6fh2G0CrmCn6k4xKaZHm9Z0QBnpfWlbRWCbA130_assertion description "[An 18-year-old man had cystic fibrosis (CF) and insulin-resistant carbohydrate intolerance characterized by (1) obesity, basal hyperinsulinemia, and hyperglucagonemia; (2) impaired oral glucose tolerance; (3) hyperinsulinemia in response to oral and intravenous (IV) administration of glucose and to IV administration of tolbutamide; (4) exaggerated gastric inhibitory polypeptide secretion following orally administered glucose; and (5) diminished sensitivity to insulin administered IV compared with other patients with CF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1305860.RA8yQiCiv6fh2G0CrmCn6k4xKaZHm9Z0QBnpfWlbRWCbA130_provenance.
• NP1305865.RAyXEL5hq3UZweuPnPwWIt6Z1g0rGiOhrUmcyjLksXb04130_assertion description "[An 18-year-old man had cystic fibrosis (CF) and insulin-resistant carbohydrate intolerance characterized by (1) obesity, basal hyperinsulinemia, and hyperglucagonemia; (2) impaired oral glucose tolerance; (3) hyperinsulinemia in response to oral and intravenous (IV) administration of glucose and to IV administration of tolbutamide; (4) exaggerated gastric inhibitory polypeptide secretion following orally administered glucose; and (5) diminished sensitivity to insulin administered IV compared with other patients with CF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1305865.RAyXEL5hq3UZweuPnPwWIt6Z1g0rGiOhrUmcyjLksXb04130_provenance.